They have approval for immediate start in those countries , is that a regulatory tick or IRB? I assume the latter otherwise they couldn’t start but then trial isn’t posted to clinical trials.gov where these things really should be available. I’m keen to look at the design in detail.
- Forums
- ASX - By Stock
- NOX
- Ann: Veyonda COVID-19 Study Approved For Immediate Start
Ann: Veyonda COVID-19 Study Approved For Immediate Start, page-7
Featured News
Add NOX (ASX) to my watchlist
|
|||||
Last
7.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.45M |
Open | High | Low | Value | Volume |
7.0¢ | 7.0¢ | 7.0¢ | $2.863K | 40.90K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 141114 | 6.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.9¢ | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 141114 | 0.066 |
1 | 100000 | 0.064 |
1 | 77000 | 0.062 |
2 | 31393 | 0.061 |
4 | 119833 | 0.060 |
Price($) | Vol. | No. |
---|---|---|
0.069 | 5000 | 1 |
0.070 | 4493 | 1 |
0.075 | 16806 | 1 |
0.079 | 10000 | 1 |
0.081 | 12345 | 1 |
Last trade - 10.21am 20/06/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Chairman
Nick Poll
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online